QuantumFP

QuantumFP, developed by QSimulate, is a quantum mechanical 3D fingerprinting platform designed to accelerate AI-driven drug discovery. By leveraging quantum mechanics, QuantumFP enables researchers to evaluate covalent bond formation effects, transform 2D molecular representations into 3D structures, and generate high-quality quantum mechanical data at scale for use in machine learning workflows.

The platform is purpose-built for computational chemists, AI/ML teams, and drug discovery organizations seeking to integrate quantum accuracy into docking scoring pipelines, warhead tuning, and large-scale molecular featurization — all at a fraction of the cost of traditional wet lab experiments.

Core Capabilities

• Automated transformation of 2D molecular representations into 3D structures with a single click
• Generation of quantum mechanical properties and descriptors for each compound in the output
• Integration into docking scoring workflows and AI/ML pipelines
• Support for warhead tuning through automated quantum mechanical evaluation of covalent bond formation
• Ability to feed machine learning models a higher volume of data with quantum-level accuracy

Key Features

• Accurate: Quantum-driven 3D characterization reliably identifies correct low-energy conformers and provides a broader array of molecular descriptors than molecular mechanics approaches can offer
• Fast: Generate 3D structures for millions of compounds in a single operation, with quantum mechanical properties included in the output for every compound
• Affordable: The platform is optimized for cost-efficient "spot instance" cloud computing, enabling calculation of vast quantities of data at significantly lower cost than wet lab experiments

Performance Benchmarks

• Throughput: More than 30,000,000 conformers generated per day
• Computing cost: Approximately $15 per 30,000 conformers (based on 1,000 molecules at 30 conformers each)
• Success rate: Greater than 99.9994%, measured across approximately 1,000,000 molecules

QuantumFP is offered by QSimulate, headquartered in Boston, MA. The platform is optimized for cloud-based deployment using spot instance computing, making enterprise-scale quantum mechanical featurization accessible and cost-effective for drug discovery teams. Additional resources including a whitepaper and webinar are available to support evaluation and adoption.